Form 4: Natera Executive John Fesko Sells Shares to Cover Tax Obligations

Natera's President and Chief Business Officer, John Fesko, sold shares of common stock on October 21 and 22, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Summary

• John Fesko, President and Chief Business Officer of Natera, Inc., reported the sale of Natera common stock on October 21 and 22, 2024.
• The sales were executed to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
• On October 21, 2024, 342 shares were sold at a weighted average price of $120.7572 per share.
• On October 22, 2024, 199 shares were sold at a price of $120.07 per share.
• Following these transactions, Fesko directly owns 114,065 shares of Natera common stock.
• The sales were conducted under a pre-arranged trading plan (Rule 10b5-1(c)) to satisfy affirmative defense conditions under the Exchange Act.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports stock sales by an executive for tax purposes, which is a common and expected practice. There is no indication of positive or negative implications for the company's performance.

Positives

• The sales were conducted under a pre-arranged trading plan (Rule 10b5-1(c)), indicating they were planned and not based on immediate market sentiment.

Industry Context

Sales of shares by company executives are a normal part of corporate governance, especially when related to RSU vesting and tax obligations. These transactions are often pre-planned under Rule 10b5-1 to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages often include stock options and RSUs, which vest over time.
• Upon vesting, executives commonly sell a portion of the shares to cover income tax obligations.
• Rule 10b5-1 trading plans are a standard practice among public company executives to manage these transactions in compliance with securities laws.
• Comparable companies like Exact Sciences (EXAS) and Guardant Health (GH) also see similar patterns of executive stock sales for tax purposes.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price due to increased selling pressure, but this is likely to be minimal given the relatively small number of shares involved and the pre-planned nature of the transactions.

Key Dates